D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 96 Citations 31,015 275 World Ranking 112 National Ranking 56
Medicine D-index 87 Citations 28,194 239 World Ranking 6762 National Ranking 3721

Overview

What is he best known for?

The fields of study he is best known for:

  • Antibiotics
  • Bacteria
  • Internal medicine

His primary scientific interests are in Microbiology, Vancomycin, Antibiotics, Staphylococcus aureus and Antibacterial agent. He interconnects Enterococcus faecalis and Virulence in the investigation of issues within Microbiology. His Vancomycin study combines topics from a wide range of disciplines, such as Internal medicine, Nomogram, Surgery and Urology.

His research integrates issues of Immunology and Intensive care medicine in his study of Antibiotics. His Drug resistance research includes elements of Penicillin, Minimum inhibitory concentration and Virology. His work deals with themes such as Plasmid, Antimicrobial, Enterococcus faecium and Multilocus sequence typing, which intersect with Antibiotic resistance.

His most cited work include:

  • The Sanford guide to antimicrobial therapy (945 citations)
  • Antimicrobial-drug resistance (903 citations)
  • Relationship of MIC and Bactericidal Activity to Efficacy of Vancomycin for Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia (769 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Microbiology, Antibiotics, Vancomycin, Antibacterial agent and Antimicrobial. His Microbiology study integrates concerns from other disciplines, such as Enterococcus faecalis and Staphylococcus aureus. His Antibiotics research is multidisciplinary, incorporating perspectives in Immunology, Drug resistance and Intensive care medicine.

His studies deal with areas such as Glycopeptide, Internal medicine and Surgery as well as Vancomycin. His Antibacterial agent study deals with Enterococcus faecium intersecting with Quinupristin/dalfopristin and Vancomycin-resistant Enterococcus. Robert C. Moellering works mostly in the field of Antimicrobial, limiting it down to concerns involving Multiple drug resistance and, occasionally, Antimicrobial stewardship.

He most often published in these fields:

  • Microbiology (60.57%)
  • Antibiotics (44.00%)
  • Vancomycin (25.14%)

What were the highlights of his more recent work (between 2007-2015)?

  • Methicillin-resistant Staphylococcus aureus (9.71%)
  • Antibiotics (44.00%)
  • Staphylococcus aureus (17.14%)

In recent papers he was focusing on the following fields of study:

Robert C. Moellering mainly focuses on Methicillin-resistant Staphylococcus aureus, Antibiotics, Staphylococcus aureus, Microbiology and Vancomycin. Robert C. Moellering has researched Methicillin-resistant Staphylococcus aureus in several fields, including Skin infection, Disease, Immunology and Intensive care medicine. His research in Antibiotics intersects with topics in Abscess, Pharmacotherapy and Drug resistance.

In his study, which falls under the umbrella issue of Staphylococcus aureus, Endocarditis, Staphylococcal infections, Pneumonia and Antibiotic resistance is strongly linked to Bacteremia. His work in the fields of Microbiology, such as Pathogen, intersects with other areas such as Eukaryote. The study incorporates disciplines such as Bacterial virulence, Therapeutic drug monitoring and Clinical trial in addition to Antibacterial agent.

Between 2007 and 2015, his most popular works were:

  • Therapeutic monitoring of vancomycin in adults summary of consensus recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. (332 citations)
  • Increasing Antibiotic Resistance among Methicillin-Resistant Staphylococcus aureus Strains (242 citations)
  • NDM-1 — A Cause for Worldwide Concern (221 citations)

In his most recent research, the most cited papers focused on:

  • Antibiotics
  • Bacteria
  • Internal medicine

The scientist’s investigation covers issues in Methicillin-resistant Staphylococcus aureus, Multiple drug resistance, Antimicrobial, Antibiotic resistance and Bacteremia. His study in Methicillin-resistant Staphylococcus aureus is interdisciplinary in nature, drawing from both Surgery, Disease and Family medicine. The various areas that Robert C. Moellering examines in his Antimicrobial study include Epistasis, Genetics and Drug.

His study looks at the relationship between Antibiotic resistance and topics such as Pneumonia, which overlap with Microbiology and Vancomycin. His Bacteremia research also works with subjects such as

  • Infection control most often made with reference to Staphylococcus aureus,
  • Skin infection together with Intensive care medicine. His biological study spans a wide range of topics, including Antibiotics and Antibacterial agent.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Antimicrobial-drug resistance

Howard S. Gold;Robert C. Moellering.
The New England Journal of Medicine (1996)

1426 Citations

Relationship of MIC and Bactericidal Activity to Efficacy of Vancomycin for Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia

George Sakoulas;Pamela A. Moise-Broder;Jerome Schentag;Alan Forrest.
Journal of Clinical Microbiology (2004)

1195 Citations

The Sanford guide to antimicrobial therapy

David N. Gilbert;Robert C. Moellering;George M. Eliopoulos;Henry F. Chambers.
(2010)

1167 Citations

Emergence of Enterococcus as a Significant Pathogen

Robert C. Moellering.
Clinical Infectious Diseases (1992)

751 Citations

The Rationale for Revising the Clinical and Laboratory Standards Institute Vancomycin Minimal Inhibitory Concentration Interpretive Criteria for Staphylococcus aureus

Fred C. Tenover;Robert C. Moellering.
Clinical Infectious Diseases (2007)

582 Citations

Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility.

L B Rice;S H Willey;G A Papanicolaou;A A Medeiros.
Antimicrobial Agents and Chemotherapy (1990)

503 Citations

Therapeutic monitoring of vancomycin in adults summary of consensus recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.

Michael J. Rybak;Michael J. Rybak;Ben M. Lomaestro;John C. Rotschafer;Robert C. Moellering.
Pharmacotherapy (2009)

501 Citations

Linezolid: The first oxazolidinone antimicrobial

Robert C. Moellering.
Annals of Internal Medicine (2003)

470 Citations

Accessory Gene Regulator Group II Polymorphism in Methicillin-Resistant Staphylococcus aureus Is Predictive of Failure of Vancomycin Therapy

Pamela A. Moise-Broder;George Sakoulas;George M. Eliopoulos;Jerome J. Schentag.
Clinical Infectious Diseases (2004)

467 Citations

Increasing Antibiotic Resistance among Methicillin-Resistant Staphylococcus aureus Strains

George Sakoulas;Robert C. Moellering.
Clinical Infectious Diseases (2008)

363 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Robert C. Moellering

Michael J. Rybak

Michael J. Rybak

Eugene Applebaum College of Pharmacy and Health Sciences

Publications: 134

Ronald N. Jones

Ronald N. Jones

JMI Laboratories

Publications: 89

George Sakoulas

George Sakoulas

University of California, San Diego

Publications: 85

Louis B. Rice

Louis B. Rice

Brown University

Publications: 69

George M. Eliopoulos

George M. Eliopoulos

Beth Israel Deaconess Medical Center

Publications: 64

Arnold S. Bayer

Arnold S. Bayer

University of California, Los Angeles

Publications: 63

Barbara E. Murray

Barbara E. Murray

The University of Texas at Austin

Publications: 50

Cesar A. Arias

Cesar A. Arias

The University of Texas Health Science Center at Houston

Publications: 49

Michael S. Gilmore

Michael S. Gilmore

Massachusetts Eye and Ear Infirmary

Publications: 48

Marcus J. Zervos

Marcus J. Zervos

Wayne State University

Publications: 44

Fred C. Tenover

Fred C. Tenover

Cepheid

Publications: 43

Anton Y. Peleg

Anton Y. Peleg

Monash University

Publications: 43

Helio S. Sader

Helio S. Sader

JMI Laboratories

Publications: 34

David L. Paterson

David L. Paterson

University of Queensland

Publications: 34

Marin H. Kollef

Marin H. Kollef

Washington University in St. Louis

Publications: 34

Po-Ren Hsueh

Po-Ren Hsueh

National Taiwan University

Publications: 33

Trending Scientists

Miguel Castro

Miguel Castro

Microsoft (United States)

Gregory E. Kersten

Gregory E. Kersten

Concordia University

Iain Raeburn

Iain Raeburn

Victoria University of Wellington

Gerhard Schmidt

Gerhard Schmidt

Kiel University

Costas S. Iliopoulos

Costas S. Iliopoulos

King's College London

Martin Billeter

Martin Billeter

University of Gothenburg

Tehshik P. Yoon

Tehshik P. Yoon

University of Wisconsin–Madison

Ciarán Condon

Ciarán Condon

Université Paris Cité

Mary C. Dinauer

Mary C. Dinauer

Washington University in St. Louis

Dennis A. Ausiello

Dennis A. Ausiello

Harvard University

Robert B. Sim

Robert B. Sim

University of Oxford

John Webb

John Webb

La Trobe University

Luc Abbadie

Luc Abbadie

Université Paris Cité

Erminio Capitani

Erminio Capitani

University of Milan

Nima Rezaei

Nima Rezaei

Tehran University of Medical Sciences

Urho M. Kujala

Urho M. Kujala

University of Jyväskylä

Something went wrong. Please try again later.